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A B S T R A C T
This study investigated the effects of aqueous extract of Ocimum gratissimum leaf (AOGL)
on some markers of renal function in rats with gentamicin-induced nephropathy. Thirty
adult male Wistar rats were used for this study. They were divided into 5 groups as follows:
Group 1 (the control) (n = 5) received distilled water daily by oral route for the whole period
of the study. Group 2 (the toxic control) (n = 10) received 100 mg/kg/day of gentamicin i.p.
for a week. Groups 3, 4, and 5 (n = 5) were pre-treated with gentamicin as the Group 2 rats,
after which they received 100, 200 and 400 mg/kg/day each of AOGL p.o., respectively, for 14
days. Rats in each groups were placed inside separate metabolic cages to obtain their food
consumption, water intake and urine output for 24 hours after the last administration. Markers
of renal function such as creatinine, urea and total protein were determined both in the
plasma and urine. Oxidative stress markers such as TBARS and GSH were assayed in the
tissue homogenate. Creatinine clearance was calculated using a standard formula. Genta-
micin treatment induced significant (p < 0.05) increases in urine output, plasma urea, creatinine,
urinary protein, relative kidney weight and TBARS in the toxic control when compared to
the control group. Significant decreases (p < 0.05) in urine creatinine and GSH were also as-
sociated with gentamicin administration. Post-treatment with AOGL caused significant
increases in food consumption, body weight, water intake, urine creatinine, and GSH, and
significant (p < 0.05) decreases in urine output, plasma creatinine, urea, TBARS and urine
total protein in the treated groups when compared with the toxic control group. This was
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further evident by a significant improvement or reversal of the histopathological
alterations of kidney tissues in the groups treated with AOGL. The results of this study
indicated that AOGL ameliorated the kidney injury caused by gentamicin in rats. Hence, the
extracts have the potential of being used for the management of gentamicin-induced
nephropathies.
© 2016 Mansoura University. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
1. Introduction
Gentamicin (Gen.) is an antibiotic that is widely used against
serious and life-threatening gram-negative bacterial infec-
tion. However, the clinical use of gentamicin is limited due to
its nephrotoxicity [1]. Gentamicin induces nephrotoxicity via
oxidative and nitrosative stress [2]. It also causes nephrotox-
icity by inhibiting protein synthesis in renal cells. This
mechanism specifically causes necrosis of cells in the proxi-
mal tubule, resulting in acute tubular necrosis which can
lead to acute renal failure [3]. Gentamicin binds to the phos-
pholipids of the cell membrane of the renal tubules and
enters the cells, then it binds to sub-cellular organelles and
alters mitochondrial respiration, while small amounts may
be taken up by lysosomes [4]. In addition, induction of acute
tubular necrosis, glomerular damage and renal inflammation
are the major events implicated in gentamicin nephrotoxic-
ity [5,6]. Ocimum gratissimum (OG) is an herbaceous plant that
belongs to the Labiatae family. The plant is indigenous to
tropical areas especially India and West Africa. In Nigeria, it
is found in the savannah and coastal areas. It is cultivated in
Sri Lanka, South Sea Islands, and also within Nepal, Bengal,
Chittagong and Deccan [7]. It is known by various names in
different parts of the world. In India it is known by its several
vernacular names, the most commonly used ones being
Vriddhutulsi (Sanskrit), Ram tulsi (Hindi), and Nimma tulasi
(Kannada). In the southern part of Nigeria, the plant is called
“effinrin-nla” by the Yoruba speaking tribe. It is called “Ahuji”
by the Igbos, while in the Northern part of Nigeria, the Hausas
call it “Daidoya” [8]. OG has been used extensively in the
traditional system of medicine in many countries. In the
north east of Brazil, it is used for medicinal, condiment and
culinary purposes. The flowers and the leaves of this plant
are rich in essential oils so it is used in preparation of teas
and infusion [9]. In the coastal areas of Nigeria, the plant is
used in the treatment of epilepsy, high fever and diarrhea [8].
In the savannah areas decoctions of the leaves are used to
treat mental illness [10]. OG is used by the Ibos of Southeast-
ern Nigeria in the management of baby’s cord, to keep the
wound surfaces sterile. It is also used in the treatment of
fungal infections, fever, cold and catarrh [11]. Despite all these
medicinal values of O. gratissimum, there is a paucity of litera-
ture on the use of this plant in the treatment of drug-
induced kidney injury. Therefore, this study is aimed at
investigating the effect of aqueous extract of Ocimum gratissimum
(AOGL) on markers of renal function in rats following genta-
micin administration.
2. Materials and methods
2.1. Drugs and materials
Gentamicin injection 80 mg/2 ml (manufactured by Shanxi
Shuguang Pharmaceutical Co., limited) is marketed as an an-
tibiotic drug against a wide variety of pathogenic gram negative
and positive bacteria.
Metabolic cages used for this study were fabricated by
Central Technological Laboratory and Workshops (CTLW), OAU,
Ile-Ife.
2.2. Plant extraction
The plant leaves were collected, washed, air dried under shade
and ground into fine powder using a blender. The aqueous
extract was obtained by extracting the powdered leaves (323 g)
with 3 liters of distilled water in an electric shaker for 48 hours.
The extract was filtered through Whatman No. 1 (Whatman
International Ltd, Maidstone, UK) paper and evaporated under
reduced pressure using a rotary evaporator.The residue (33.60 g)
was kept in a bottle with a tight fitting cover until it was needed
for the study.
Extraction yield in %
10.4%
= ×
=
33 60 323 100.
.
2.3. Animal care and management
Sixty-five adult male Wistar rats weighing 150 g–200 g were used
for this study; they were obtained from the Animal House of
the College of Health Sciences, Obafemi Awolowo University,
Ile-Ife, and were housed in a plastic cage. The animals were
kept inside metabolic cages under normal environmental con-
ditions of light/dark cycle and had free access to standard rodent
pellet diet (Caps Feed PLC Osogbo, Nigeria) and water.They were
allowed to acclimatize in the laboratory for two weeks before
the commencement of the study. The experimental proce-
dures adopted in this study were in strict compliance with the
Experimental Animal Care and Use of Laboratory Animals in
Biomedical Research, College of Health Sciences, Obafemi
Awolowo University, Ile-Ife.
2.4. Experimental design
The rats were divided into 5 groups as follows: Group 1 (the
control) consisting of 5 rats received 2 ml/kg distilled water daily
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by oral route for the whole period of study (2 weeks). Twenty-
four hours after the last administration of distilled water, the
rats were sacrificed by cervical dislocation. Group 2 (the toxic
control) consisted of 10 rats, each of which received 100 mg/
kg/day of gentamicin i.p. for a week. They were left untreated
with aqueous extract of Ocimum gratissimum (AOGL) for 2 weeks.
Five of the rats were sacrificed twenty-four hours after the last
administration of gentamicin, while the remaining 5 rats were
sacrificed on the 14th day of recovery period. Groups 3, 4 and
5 consist of 5 rats each. They were pre-treated with gentami-
cin as the Group 2 rats, after which they received 100, 200 and
400 mg/kg/day each of AOGL p.o., respectively, for 14 days.
Rats from each group were sacrificed on the 14th day of
treatment with AOGL. Throughout the study period, the body
weights of the rats were measured once a week. Their 24-
hour food consumption, water intake and urine output were
also recorded weekly. Renal creatinine clearance was calcu-
lated for all the groups using standard formula (C = U × V / P).
C clearance U urine creatinine concentration
V urine flow rate
= =
=
, ,
volume of urine time
P plasma creatinine concentration
( )
=
,
.
2.5. Measurement of body weight
The body weight of the rats were measured throughout the
study period using a digital weighing scale (Camry weighing
balance; China) to access the weight gain or loss in each group.
2.6. Measurement of food consumption, water intake and
urine volume
The food consumption and water intake of the rats were de-
termined by taking the difference between the previous weight
and volumes respectively from the left over after 24 hours. The
value obtained was taken as the daily food consumption and
water intake of the group.The volumes of water consumed and
urine produced by each rat were measured with a measuring
cylinder and the food consumption by the digital weighing scale.
2.7. Biochemical assay
About 3 ml of whole blood collected into an EDTA tube was
centrifuged at 4000 rpm for 15 min using a Cold Centrifuge
(Centurium Scientific, Model 8881, UK). The plasma obtained
was analyzed for creatinine, urea and total protein. Similar pro-
cedure was applied to the urine sample.
2.7.1. Plasma creatinine and urea
The plasma creatinine concentration was estimated by colo-
rimetric method [12] using the laboratory protocol outlined by
Randox Manual/RX Monza CR 510 (standard laboratory kit).
2.7.2. Urine creatinine and urea
Urine samples obtained were diluted 1 + 49 with distilled water
before 0.1 ml of the diluted urine sample was pipetted into the
test tube for creatinine and urea determination.
2.7.3. Protein determination
Protein determination was carried out according to the method
of Lowry et al. [13] as described by Holme and Peck [14].
2.8. Creatinine clearance
This was determined using the following equation:
2.9. Measurement of non-enzymatic antioxidants
The kidneys of the rats were carefully excised and weighed.
One of the kidneys was homogenized with 10 ml of sucrose
solution (0.25 M) using Electric Homogenizer (SI601001).The ho-
mogenate was centrifuged at 3000 rpm for 20 minutes and the
supernatant was collected for the assessment of glutathione
and TBARS activities.
2.9.1. Estimation of reduced glutathione (GSH) and
estimation of thiobarbituric acid reactive substance (TBARS)
Reduced glutathione (GSH) was measured by the method of
Beutler et al. [15] and TBARS level was determined by the
method of Ohkawa et al. [16].
2.10. Histopathological studies
The tissues were fixed in 10% formo-saline to prevent putre-
faction and autolysis, embedded in paraffin wax, sectioned and
stained with hematoxylin and eosin (H&E) for histological analy-
sis. The slides were examined under a light microscope
(Olympus CH; Olympus, Tokyo, Japan) and photomicrographs
were taken with a Leica DM 750 Camera at ×400 magnification.
2.11. Statistical analysis
The results obtained were expressed as mean ± SEM. The data
were analyzed using one-way ANOVA followed by Newman–
Keuls test using Graph Pad 5.03 (Graph Pad Software Inc., CA,
USA). The results were considered significant when p < 0.05.
3. Results
3.1. Food consumption and body weight
The food consumption and body weight of the control group
increased significantly (p < 0.05) throughout the study period
(Table 1). An insignificant increase in food consumption and
body weight was observed in the gentamicin treated rats when
Creatinine clearance
urine creatinine mol L volume of uri
=
×( )μ ne ml hrs
plasma creatinine mol L
( )( )
( )
24 1440 min
.μ
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compared with its pre-treatment values during the 8-day treat-
ment with gentamicin (Table 1). However, a significantly higher
food consumption and body weight was recorded in the rats
treated with AOGL after gentamicin administration when com-
pared with their pre-treatment values and during gentamicin
treatment (p < 0.05) (Table 1). The food consumption and body
weight of the toxic recovery group were significantly higher
(p < 0.05) when compared with its pre-treatment values and
after the administration of gentamicin.
3.2. Water intake and urine volume
The urine volume of the toxic control group was significantly
higher (p < 0.05) than that of its pre-treatment value (Table 2).
This increase was accompanied by a reduction in water intake,
which was significantly lower (p < 0.05) than its pre-treatment
value. At the end of the 14-day treatment with AOGL, the water
intake of the treated rats was significantly higher (p < 0.05) than
that of their pre-treatment values and 8-day gentamicin treat-
ment period except for rats treated with 400 mg/kg/day of AOGL,
which showed no significant difference in water intake com-
pared to its pre-treatment value and during gentamicin
administration (Table 2). The experimental groups had a sig-
nificantly higher urine volume (p < 0.05) during the 8 days of
treatment with gentamicin when compared with their pre-
treatment values. However, their urine volume dropped
significantly at the end of treatment with AOGL (p < 0.05). Simi-
larly, rats that were allowed a 2-week recovery period after
gentamicin treatment had a significantly lower (p < 0.05) urine
volume compared to the value obtained during gentamicin ad-
ministration (Table 2).
3.3. Plasma and urine creatinine, urea and total protein
A significant increase in the plasma creatinine and urea con-
centrations was observed in the toxic control and the recovery
group when compared with the control rats (p < 0.05) (Figs. 1
and 2). The plasma creatinine and urea concentrations of the
rats treated with AOGL were found to be significantly lower
(p < 0.05) than that of the toxic control group. The concentra-
tions of urea and creatinine in the plasma of the treated rats
were not significantly different from that of the control groups,
but the rats that were allowed a 2-week recovery period after
gentamicin treatment had a significantly higher (p < 0.05)
plasma creatinine concentration when compared to the control
rats (Figs. 1 and 2).
The plasma total protein of the toxic control group and the
AOGL treated group reduced significantly (p < 0.05) when com-
pared with the control group (Fig. 3). Similarly, the toxic recovery
group had significantly lower (p < 0.05) plasma total protein con-
centration compared to the control group (Fig. 3).
The urine creatinine concentration of the toxic control was
observed to be significantly lower (p < 0.05) than that of the control
group (Fig. 4). However, the urine creatinine concentration of the
treated rats and recovery group was significantly higher (p < 0.05)
than that of the toxic control, but significantly lower (p < 0.05)
Table 1 – Effect of aqueous extract of Ocimum gratissimum on food consumption (g) and body weight in gentamicin-
induced nephrotoxicity in rats.
Food consumption Body weight
Pre-treatment Gentamicin
treatment
14 days’
treatment
Pre-treatment Gentamicin
treatment
14 days’
treatment
Control 18.00 ± 1.26 21.40 ± 2.91 26.40 ± 0.68* 204.0 ± 3.55 212.6 ± 3.89 226.0 ± 2.92*,†
Toxic control 27.00 ± 2.00 33.60 ± 5.27 – 188.0 ± 12.41 195.6 ± 11.74 –
Toxic recovery 15.00 ± 0.76 14.40 ± 1.63 26.00 ± 1.4*,† 94.00 ± 1.73 101.2 ± 2.44 136.0 ± 4.14*,†
100 mg AOGL 11.00 ± 1.79 14.80 ± 2.15 21.00 ± 2.04*,† 98.00 ± 3.86 87.40 ± 5.14 132.8 ± 10.00*,†
200 mg AOGL 12.60 ± 2.56 17.80 ± 1.16 24.40 ± 3.14*,† 117.4 ± 9.05 118.8 ± 8.62 142.0 ± 6.61*,†
400 mg AOGL 15.60 ± 1.69 17.20 ± 2.06 20.80 ± 1.77*,† 92.20 ± 4.34 96.60 ± 6.38 129.8 ± 7.94*,†
Values are given as mean ± SEM. * = Significantly different from pre-treatment values. † = Significantly different from toxic control (p < 0.05).
AOGL, aqueous extract of Ocimum gratissimum.
Table 2 – Effect of aqueous extract of Ocimum gratissimum on water consumption (ml) and urine volume (ml) in
gentamicin-induced nephrotoxicity in rats.
Water consumption Urine output
Pre-treatment Gentamicin
treatment
14 days’
treatment
Pre-treatment Gentamicin
treatment
14 days’
treatment
Control 31.00 ± 2.12 30.60 ± 9.51 29.20 ± 3.40 9.20 ± 1.02 10.90 ± 0.95 9.40 ± 1.45
Toxic control 17.40 ± 2.16 13.00 ± 0.95 – 6.00 ± 0.89 9.50 ± 0.80* –
Toxic recovery 10.00 ± 1.38 13.80 ± 1.59 33.50 ± 4.29* 5.00 ± 0.45 8.90 ± 1.07* 3.12 ± 1.32†
100 mg AOGL 9.400 ± 0.60 15.00 ± 1.92 29.00 ± 3.14*,† 3.90 ± 0.58 7.60 ± 0.37* 4.25 ± 1.74†
200 mg AOGL 11.20 ± 0.97 16.60 ± 2.38 28.00 ± 3.56*,† 3.90 ± 0.43 7.00 ± 1.19* 4.60 ± 1.45†
400 mg AOGL 11.60 ± 1.86 23.60 ± 2.75 30.40 ± 4.57 4.50 ± 0.54 8.10 ± 1.22* 4.20 ± 0.97†
Values are given as mean ± SEM. * = Significantly different from pre-treatment values. † = Significantly different from toxic control (p < 0.05).
AOGL, aqueous extract of Ocimum gratissimum.
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than that of the control group (Fig. 4). The urine concentration
of urea in the toxic control group was significantly higher (p < 0.05)
than that of the control group (Fig. 5). However, AOGL treated
groups and the toxic recovery group had a significantly lower
(p < 0.05) urine concentration of urea when compared with the
toxic control group, which was not significantly different from
the control rats (Fig. 5).The urine total protein concentration of
the toxic control was significantly higher (p < 0.05) when com-
pared to the control group (Fig. 6).The toxic recovery group had
urine total protein concentration which was significantly lower
(p < 0.05) than that of the control and toxic control. The group
treated with 100 mg/kg/day of AOGL had a significantly higher
(p < 0.05) urine total protein concentration when compared to
the toxic recovery group, which was significantly lower (p < 0.05)
than that of the toxic control group (Fig. 6). The plasma total
protein concentration of rats treated with 400 mg/kg/day of
AOGL was significantly higher (p < 0.05) than that of the toxic
recovery group.
3.4. Relative kidney weight, TBARS and GSH
A significant increase in the relative kidney weight was ob-
served in the toxic control group, toxic recovery group and the
AOGL treated rats when compared with the control group
(p < 0.05) (Fig. 7).
The TBARS and GSH of the toxic control group were sig-
nificantly higher (p < 0.05) when compared with the control
group, while the TBARS and GSH of the toxic recovery group
and rats treated with AOGL decreased significantly (p < 0.05)
when compared with the toxic control group (Figs. 8 and 9).
Fig. 1 – Effect of aqueous extract of Ocimum gratissimum on plasma creatinine level in gentamicin-induced kidney injury in
rats. Values are given as mean ± SEM. * = Significantly different from control. γ = Significantly different from toxic control
(p < 0.05).
Fig. 2 – Effect of aqueous extract of Ocimum gratissimum on plasma urea in gentamicin-induced kidney injury in rats. Values
are given as mean ± SEM. * = Significantly different from control. γ = Significantly different from toxic control (p < 0.05).
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3.5. Creatinine clearance
A significant decrease in the renal creatinine clearance was ob-
served in the toxic control group, toxic recovery group and the
AOGL treated rats when compared with the control group
(p < 0.05) (Fig. 10).
3.6. Histological examination
The photomicrograph of the toxic control showed decreased
cellularity in the glomeruli (G), loss of cellular constituents
(double arrow) and densely eosinophilic cast in the lumen of
the tubules (dashed arrow) resulting in atrophy and severe
cloudy swelling of the distal convoluted tubule (yellow arrow)
when compared with the control, which showed intact renal
corpuscles with normal appearing glomeruli (G) and tubules
(T), as well as intact Bowman’s space (black arrow) and epi-
thelial lining of Bowman’s capsule (arrowhead) (Figs. 11 and
12), while the toxic recovery group showed marked decrease
cellularity in the glomeruli, loss of cellular constituents of
tubules (double arrow), densely eosinophilic (‘colloid’) cast in
the lumen of some tubules (dashed arrow), cloudy swelling/
inflammation of the proximal and distal convoluted tubules
(yellow arrow) (Fig. 13).
The photomicrographs of the kidneys of rats treated with
graded doses of AOGL revealed that the glomeruli (G) and
surrounding Bowman’s space (black arrow) are mostly intact.
There is slight loss of cellular constituents of tubules and no
Fig. 3 – Effect of aqueous extract of Ocimum gratissimum on plasma total protein in gentamicin-induced kidney injury in
rats. Values are given as mean ± SEM. * = Significantly different from control (p < 0.05).
Fig. 4 – Effect of aqueous extract of Ocimum gratissimum on urine creatinine in gentamicin-induced kidney injury in rats.
Values are given as mean ± SEM. * = Significantly different from control. γ = Significantly different from toxic control
(p < 0.05).
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eosinophilic (‘colloid’) casts are observed in the lumen of tubules
(Figs. 14–16).
4. Discussion
In this study, an insignificant increase in food consumption and
body weight was observed in the gentamicin treated rats when
compared with its pre-treatment values.This is in contrast with
the findings of Erdem et al. [4] and El-Zawahry and Abu El Kheir
[17], who reported that gentamicin administration caused re-
duction in food intake and body weight.
Morley et al. [18] reported that there was a physiological
decline in food intake with aging which is multi-factorial and
involves both peripheral and central mechanisms. Altered
hedonic qualities of food occur due to alterations in taste and,
more particularly, smell with aging.They further explained that
a decline in adaptive relaxation of the fundus of the stomach
and an increased rate of antral filling appear to play a role in
the early satiation seen in many aged persons. Cholecystoki-
nin levels are increased with aging and aged persons are more
sensitive to the satiating effects of this gut hormone. For these
reasons, the increase in food consumption and body weight
that was observed in the gentamicin treated rats may be due
to the wide differences in the age and body weight of the rats
Fig. 5 – Effect of aqueous extract of Ocimum gratissimum on urine urea in gentamicin-induced kidney injury in rats. Values
are given as mean ± SEM. * = Significantly different from control. γ = Significantly different from toxic control (p < 0.05).
Fig. 6 – Effect of aqueous extract of Ocimum gratissimum on urine total protein in gentamicin-induced kidney injury in rats.
Values are given as mean ± SEM. * = Significantly different from control. γ = Significantly different from toxic control
(p < 0.05). α = Significantly different from toxic recovery group (p < 0.05).
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used in this study (100–150 g) compared with that of the rats
used by El-Zawahry and Abu El Kheir [17] (210–230 g).
Gentamicin has been reported to cause a decrease in the
number of cytokines cells (such as CD3(+), CD56(+), CD3(+),
CD8(+), CD3(+), CD56(+)) with some cytotoxicity [19]. Cytokines
are immune-regulatory peptides released in response to chronic
inflammation, infections, injuries, and neoplasms [20]. Cytokines
are potent anorectic agents, they decrease serum albumin,
induce lipolysis, produce muscle protein breakdown, and induce
nitrogen loss [20]. These have a variety of effects that can lead
to severe malnutrition [20]. Hence, the significant increase in
food consumption and body weight that was observed in the
toxic recovery group when compared with the pre-treatment
values is an indication of the ability of gentamicin to de-
crease the numbers of cytokines in the rats’ body.
Study has shown that administration of AOGL in rats caused
significant histological changes in the intestines, revealing the
presence of increased villi and larger goblets cells [21]. The in-
crease in the numbers of villi in the intestine facilitates increase
in nutrient absorption due to increase in the surface area of
the intestine [22]. Furthermore, AOGL enhances anti-diarrhea
effect by inhibiting intestinal motility, partly via muscarinic re-
ceptor inhibition [23], thereby facilitating nutrient absorption
in the intestine. The significant increase in body weight that
was seen in the experimental groups treated with AOGL may
be as a result of AOGL-induced inhibition of the intestinal mo-
tility, together with increase in the number of villi of the
intestine and larger goblets cells, which favor rapid absorp-
tion of nutrient from the gastro-intestinal tract. However, this
is not in agreement with the report of Ajibade et al. [24], who
Fig. 7 – Effect of aqueous extract of Ocimum gratissimum on the relative kidney weight in gentamicin-induced kidney injury
in rats. Values are given as mean ± SEM. * = Significantly different from control (p < 0.05).
Fig. 8 – Effect of aqueous extract of Ocimum gratissimum on TBARS in gentamicin-induced kidney injury in rats. Values are
given as mean ± SEM. * = Significantly different from control. γ = Significantly different from toxic control (p < 0.05).
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reported that AOGL administered at different doses caused a
significant decrease in the body weight.This disparity may have
resulted from the differences in the doses administered to the
rats. While Ajibade et al. used 400, 800, 1600 and 3200 mg/kg/
bw, in this study 100, 200 and 400 mg/kg/bw were used. Another
possible explanation for the significant increase in food con-
sumption and body weight that was observed in the groups
treated with AOGL could be due to its hypoglycemic property
attributed to flavonoids and other phytochemical constitu-
ents [25]. The extract also contains major mineral elements,
e.g. calcium, chloride, manganese, magnesium, zinc and po-
tassium, which might also play a contributory role in enhancing
its hypoglycemic property [25]. Administration of the AOGL
caused a significant reduction in plasma glucose level in
streptozotocin induced diabetic rats [26]. Decrease in the plasma
glucose level is said to inhibit the satiety center, thus activat-
ing the feeding center to increase appetite leading to increase
in food intake [27]. Leptin, a cytokine-like peptide hormone that
is secreted from adipose cells deficiency, has been found to be
responsible for the hyperphagia and obesity of the geneti-
cally obese mouse [28]. Hence, the increase in food consumption
and body weight of rats treated with AOGL is indicative of its
ability to reduce the secretion of leptin. This requires further
study.
The significant increase in urine volume that was ob-
served in the toxic control rats without a corresponding increase
Fig. 9 – Effect of aqueous extract of Ocimum gratissimum on GSH in gentamicin-induced kidney injury in rats. Values are
given as mean ± SEM. * = Significantly different from control. γ = Significantly different from toxic control (p < 0.05).
Fig. 10 – Effect of aqueous extract of Ocimum gratissimum on creatinine clearance in gentamicin-induced kidney injury in
rats. Values are given as mean ± SEM. * = Significantly different from control. γ = Significantly different from toxic control
(p < 0.05).
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in water intake may lead to dehydration and severe deple-
tion of the major electrolytes of their body fluid with the
attendant consequences on the cardiovascular system.This ob-
served change in urine volume is in accordance with the finding
of El-Zawahry and Abu El Kheir [17], who reported that gen-
tamicin administration to rats induced polyuria. However, the
water intake of the toxic recovery group and rats treated with
AOGL increased significantly without a corresponding in-
crease in urine output. This could be due to an attempt by the
rats to restore the body fluid volume resulting from dehydra-
tion that followed gentamicin treatment or increased osmolarity
caused by depletion of their body fluid. This leads to stimu-
lation of osmoreceptor cells which activate the thirst center
in the hypothalamus to facilitate increase in water intake.
The significant increase in relative kidney weight that was
observed in the toxic control group and toxic recovery group
may be due to inflammation in response to injury caused by
this drug. This is corroborated by the photomicrograph of the
Fig. 11 – Photomicrograph of the kidney of the control (CN).
H&E ×400. Intact renal corpuscles with normal appearing
glomeruli (G) and tubules (T), including the PCT (P) and DCT
(D), are seen in control, as well as intact Bowman space
(black arrow) and epithelial lining of Bowman capsule
(arrowhead).
Fig. 12 – Photomicrograph of the kidney of the toxic control
(TX). H&E ×400. Decreased cellularity in the glomeruli, loss
of cellular constituents of tubules (double arrow), densely
eosinophilic (‘colloid’) cast in the lumen of some tubules
(dashed arrow) resulting in atrophy, loss of epithelia cells
and severe cloudy swelling/inflammation of the distal
convoluted tubules (yellow arrow) are observed in the
toxic control group.
Fig. 13 – Photomicrograph of the kidney of toxic recovery
group. H&E ×400. Marked decreased cellularity in the
glomeruli, loss of cellular constituents of tubules (double
arrow), densely eosinophilic (‘colloid’) cast in the lumen of
some tubules (dashed arrow), and cloudy swelling/
inflammation of the proximal and distal convoluted
tubules (yellow arrow) are seen in the toxic recovery
group.
Fig. 14 – Photomicrograph of the kidney of 2 weeks’
treatment with 100 mg/kg/day of AOGL. H&E ×400.
Glomeruli (G) and surrounding Bowman’s space (black
arrow) are mostly intact. There is slight loss of cellular
constituents of tubules and no eosinophilic (‘colloid’) casts
are observed in the lumen of tubules.
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kidney of this group which showed severe cloudy swelling of
the renal tubules. Similar observation was made by El-Zawahry
and Abu El Kheir [17]. Also, a significant increase in relative
kidney weight was observed in the groups treated with AOGL.
This finding is not in agreement with Sahouo et al. [29], who
reported that AOGL exhibited an anti-inflammatory effect on
the kidney of rats. The observed discrepancy is likely attrib-
utable to the duration of administration of AOGL.
The plasma creatinine and urea concentrations of the
toxic control group were significantly higher than that of
the control rats. The creatinine and urea concentrations in
the urine reduced significantly in this group compared to the
control. These observed changes are in accordance with
the report of Pedrazha-Chaverri et al. [30], who reported that
administration of gentamicin caused marked impairment in
renal function. The decrease in urine creatinine is a further
evidence of reduced ability of the renal tubules to extract
and remove creatinine from the plasma of the toxic control
rats. The elevated concentration of plasma urea observed
may have resulted from the inability of the glomeruli to filter
urea. A significant decrease toward normal plasma level of
creatinine and urea that was observed in the toxic recovery
group is an indication of tubular regeneration resulting from
the release of reparative and prosurvival factors from the
distal tubular cells [31]. The marked decrease in plasma cre-
atinine and urea in AOGL treated groups is in conformity
with report of other researchers, who reported that AOGL
decreased serum urea, creatinine, uric acid, urine volume,
urinary protein and increased urine creatinine level in cisplatin
induced nephrotoxicity in rats [32,33].
A significant decrease in renal creatinine clearance that
was observed in the toxic control and toxic recovery group is
in agreement with the report of Raheem et al. [34] and Bibu
et al. [35] that gentamicin administration to rats reduced
their glomerular filtration rate and renal blood flow, resulting
from a rise in renal vascular resistance or damage to the
glomerular capillary endothelium leading to impairment in
glomerular function. Similarly, a significant decrease in renal
creatinine clearance was observed in rats treated with AOGL
when compared to the control. However, the creatinine clear-
ance of these rats increased when compared to the toxic
control group. This is an indication of improved blood flow to
the kidney as well as repair of kidney tissue damage caused
by gentamicin.
A significant increase in the urinary total protein was ob-
served in the toxic control group. It is an evidence of
inflammation of the glomerular capillaries. This observed
change is in accordance with the result of El-Zawahry and Abu
El Kheir [17], who reported that gentamicin administration to
rats induced proteinuria. In contrast, rats treated with AOGL
showed a decrease in urine protein. This may be due to the
antioxidant properties of AOGL since it has been found that
reactive oxygen species (ROS) may be involved in the impair-
ment of glomerular filtration [2].
A significant increase in the TBARS level and significant de-
crease in GSH level that were observed in the toxic control group
are evidence of increased lipid peroxidation, which is an in-
dicator of oxidative stress.This observed change is in conformity
with the report of Reddy et al. [36], who reported that genta-
micin administration caused oxidative damage to the kidney.
Also a significant decrease in the TBARS level and increase in
GSH level were observed in the toxic recovery group when com-
pared with the control group. This finding is an indication of
the release of reparative and prosurvival factors from the distal
tubular cells [37]. Furthermore, a significant decrease in the
TBARS and increase in GSH level were observed in the AOGL
treated group when compared with the control group. This
is in agreement with Reddy et al. [36], who reported that
simvastatin increased GSH and decreased TBARS in gentami-
cin induced kidney injury. The change observed may be due
to the anti-oxidant activities of AOGL.
Fig. 15 – Photomicrograph of the kidney of 2 weeks’
treatment with 200 mg/kg/day of AOGL. H&E ×400.
Glomeruli (G) and surrounding Bowman’s space (black
arrow) are mostly intact. There is slight loss of cellular
constituents of tubules and no eosinophilic (‘colloid’) casts
are observed in the lumen of tubules.
Fig. 16 – Photomicrograph of the kidney of 2 weeks’
treatment with 400 mg/kg/day of AOGL. H&E ×400 (right).
Glomeruli (G) and surrounding Bowman’s space (black
arrow) are mostly intact. There is slight loss of cellular
constituents of tubules and no eosinophilic (‘colloid’) casts
are observed in the lumen of tubules.
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5. Conclusion
This study demonstrated the nephron-restorative effect of O.
gratissimum in gentamicin induced nephrotoxicity in rats. The
ameliorative effect of O. gratissimum is evident by a remark-
able restoration of markers of renal function such as protein,
urea, creatinine levels, creatinine clearance and antioxidant
enzymes in gentamicin treated rats.
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